Home » Newsletters » BioWorld

BioWorld

Nov. 4, 1991

View Archived Issues

IAMIN DECREASES WOUND HEALING TIME

TSI ACQUIRES BRITISH TESTING SERVICE

GENE THERAPY APPROACH TO IL-4

APPOINTMENTS AND ADVANCEMENTS

GROWTH HORMONE TRIALS ON PATIENTS WITH HIV

BIOGEN FILES FOR 2 MILLION-SHARE OFFERING

CENTOCOR FILES POST-TRIAL MOTION

GENE CONSTRUCT INDUCES KILLER T CELLS

COMPETITION FOR IMMUNE RESPONSE VACCINE

ALTEON RAISES $45 MILLION IN IPO

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...